Prevention of Invasive Candida Infections in the Neonatal Intensive Care Unit.
- Author:
Chun Soo KIM
1
Author Information
1. Department of Pediatrics, Keimyung University School of Medicine, Daegu, Korea. cskim@dsmc.or.kr
- Publication Type:Review
- Keywords:
Candida;
Neonatal intensive care unit;
Infection control;
Fluconazole prophylaxis
- MeSH:
Antacids;
Anti-Bacterial Agents;
Birth Weight;
Candida;
Central Venous Catheters;
Colon;
Fluconazole;
Gastrointestinal Tract;
Humans;
Incidence;
Infant;
Infant, Newborn;
Infant, Premature;
Infection Control;
Intensive Care, Neonatal;
Milk, Human;
Parenteral Nutrition;
Resin Cements;
Risk Factors;
Skin
- From:Korean Journal of Pediatric Infectious Diseases
2011;18(1):15-22
- CountryRepublic of Korea
- Language:Korean
-
Abstract:
Invasive Candida infections (ICI) have become the third most common cause of late-onset infection among premature infants in the neonatal intensive care unit (NICU). Risk factors include birth weight less than 1,000 g, exposure to more than two antimicrobials, third generation cephalosporin exposure, parenteral nutrition including lipid emulsion, central venous catheter, and abdominal surgery. Candida colonization of the skin and gastrointestinal tract is an important first step in the pathogenesis of invasive disease. Strict infection control measures against the infection should be done in the NICU. The following practices are likely to contribute to reducing the rate of ICI: (1) restriction of broad-spectrum antibiotics, antacids and steroid; (2) introduction of early feeding and promoting breast milk. Fluconazole prophylaxis may be an effective control measure to prevent Candida colonization and infections in individual units with high incidence of fungal infection. In addition, there is a need of further data including the development of resistant strains and the effect on long-term neurodevelopmental outcomes of infants exposed to drugs before the initiation of routine application of antifungal prophylaxis in the NICU.
